Mabwell(SH:688062) Shang Hai Zheng Quan Bao·2025-10-12 15:11Group 1 - Private equity firms are actively engaging in A-share company research, with over 900 firms participating in nearly 2800 research activities in September [1][2] - The technology and pharmaceutical sectors remain favored by private equity, with significant interest in companies like Maiwei Biotech, which received attention from 88 private equity firms [2][4] - The electronics sector had the highest research frequency, with 78 companies being researched 554 times, followed by mechanical equipment with 444 times [4] Group 2 - The current market environment, characterized by a weaker dollar and ongoing economic recovery in China, is expected to attract global funds to A-shares due to reasonable valuations and strong industry drivers [3] - Private equity firms are focusing on high-quality growth companies, particularly in the technology and pharmaceutical sectors, as they seek to capitalize on market fluctuations [2][4] - The coal industry and companies benefiting from "anti-involution" policies, as well as those in the technology innovation space, are highlighted as areas of potential investment opportunity [4]